Details werden geladen...
FDA Issues Guidance to Improve Collection of Pregnancy Safety Data for Drugs and Biologics | The Manila Times
Recommendations aim to help provide clearer safety information for use during pregnancy
Ähnliche Seiten
FDA Issues Draft Guidance on Genome Editing Safety Standards to Advance Gene Therapy Development | FDA
https://www.fda.gov/news-events/press-announcements/fda-issues-draft-guidance-genome-editing-safety-standards-advance-gene-therapy-development
Adjustment of guidance for 2025/26 | The Manila Times
https://www.manilatimes.net/2026/03/24/tmt-newswire/globenewswire/adjustment-of-guidance-for-202526/2306751The Power of Community to Improve Asthma and Allergy Health | The Manila Times
https://www.manilatimes.net/2026/04/30/tmt-newswire/globenewswire/the-power-of-community-to-improve-asthma-and-allergy-health/2332600Webinar to Spotlight SCR and DEF Technologies and Address EPA Guidance and Current Industry Issues | The Manila Times
https://www.manilatimes.net/2026/04/08/tmt-newswire/globenewswire/webinar-to-spotlight-scr-and-def-technologies-and-address-epa-guidance-and-current-industry-issues/2315801Ultragenyx Announces U.S. FDA Acceptance and Priority Review of the Biologics License Application (BLA) for DTX401 AAV Gene Therapy for Glycogen Storage Disease Type Ia (GSDIa) | The Manila Times
https://www.manilatimes.net/2026/02/23/tmt-newswire/globenewswire/ultragenyx-announces-us-fda-acceptance-and-priority-review-of-the-biologics-license-application-bla-for-dtx401-aav-gene-therapy-for-glycogen-storage-disease-type-ia-gsdia/2283059